EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
Active Implantable Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007
This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.
Last updated 19 April 2024. Database contains 4753 unique substances/entries.
Filter the list
|
432-350-9
|
81752-87-6
|
Skin Irrit. 2 |
|||
|
220-815-7
|
2905-69-3
|
Acute Tox. 4; STOT SE 3 |
|||
|
2-NITROBENZYLIDENE METHYL ESTER; BAY O 2787
|
400-650-9
|
39562-27-1
|
Skin Sens. 1 |
||
|
BM
|
405-270-7
|
39562-17-9
|
Skin Sens. 1 |
||
|
442-860-3
|
87333-22-0
|
Skin Sens. 1 |
|||
|
DISPERSE RED CLA 282
|
416-240-8
|
155522-12-6
|
Skin Sens. 1 |
||
|
JE 127
|
421-220-7
|
144740-59-0
|
Skin Sens. 1 |
||
|
LUGALVAN ES 9571
|
420-940-9
|
15768-07-7
|
Eye Irrit. 2; Skin Irrit. 2 |
||
|
443-120-2
|
393509-79-0
|
Eye Dam. 1 |
|||
|
MEFAT
|
404-130-2
|
105560-93-8
|
Eye Dam. 1; Skin Sens. 1 |
||
|
620-362-9
|
1918-18-9
|
Acute Tox. 4 |
|||
|
G 18-1108
|
403-270-1
|
6386-39-6
|
Acute Tox. 4 |
||
|
D,L-ESTER
|
411-040-7
|
97101-46-7
|
Acute Tox. 4; Skin Sens. 1 |
||
|
250-366-2
|
30864-28-9
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
431-720-7
|
90886-53-6
|
Skin Corr. 1B; Acute Tox. 4 |
|||
|
425-190-6
|
119916-05-1
|
STOT RE 2 |
|||
|
F7641; MTSI
|
410-550-7
|
79277-18-2
|
STOT RE 2; Resp. Sens. 1; Skin Sens. 1 |
||
|
A5546
|
402-050-2
|
59337-93-8
|
Skin Sens. 1 |
||
|
BROMBENZOAT; BROMOBENZOATE
|
410-310-1
|
70264-94-7
|
Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
||
|
MAT 9460
|
414-080-3
|
117291-73-3
|
Acute Tox. 4 |
||
|
201-185-2
|
79-20-9
|
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 |
|||
|
203-299-8
|
105-45-3
|
Eye Irrit. 2 |
|||
|
MAGME(R) 200 MONOMER
|
403-230-3
|
77402-05-2
|
Carc. 1B; Muta. 1B; Skin Corr. 1B; Skin Sens. 1 |
||
|
MAGME 100 MONOMEER
|
401-890-7
|
77402-03-0
|
Carc. 1B; Muta. 1B; Acute Tox. 4; Eye Irrit. 2 |
||
|
202-500-6
|
96-33-3
|
Flam. Liq. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
202-501-1
|
96-34-4
|
Flam. Liq. 3; Acute Tox. 3; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
|||
|
201-187-3
|
79-22-1
|
Flam. Liq. 2; Acute Tox. 2; Acute Tox. 4; Skin Corr. 1B |
|||
|
203-481-7
|
107-31-3
|
Flam. Liq. 1; Acute Tox. 4; Eye Irrit. 2; STOT SE 3 |
|||
|
200-819-5
|
74-88-4
|
Carc. 2; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Skin Irrit. 2 |
|||
|
210-866-3
|
624-83-9
|
Flam. Liq. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; Resp. Sens. 1; Skin Sens. 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
|||
|
209-132-5
|
556-61-6
|
Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
|||
|
201-297-1
|
80-62-6
|
Flam. Liq. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
FAT 40'489
|
413-040-2
|
149850-30-6
|
Skin Sens. 1 |
||
|
414-460-9
|
105726-67-8
|
Acute Tox. 4 |
|||
|
209-060-4
|
554-12-1
|
Flam. Liq. 2; Acute Tox. 4 |
|||
|
METHFAT
|
420-670-1
|
37443-42-8
|
Eye Dam. 1 |
||
|
203-475-4
|
107-25-5
|
Flam. Gas 1; Press. Gas |
|||
|
F5384
|
401-340-6
|
83055-99-6
|
Skin Sens. 1 |
||
|
236-035-5
|
13108-52-6
|
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
|||
|
N 5297
|
419-010-5
|
112941-26-1
|
Acute Tox. 4; Eye Irrit. 2 |
||
|
BETA-METHOXYACRYLSÄURE METHYLESTER
|
412-900-4
|
5788-17-0
|
Skin Sens. 1 |
||
|
435-500-1
|
152460-07-6
|
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
|||
|
209-765-7
|
592-62-1
|
Carc. 1B; Repr. 1B |
|||
|
246-910-3
|
25376-45-8
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1 |
|||
|
203-624-3
|
108-87-2
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
228-652-3
|
6317-18-6
|
Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
|||
|
247-714-0
|
26447-40-5
|
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
429-320-2
|
24748-23-0
|
Org. Perox. B; Asp. Tox. 1; Skin Irrit. 2; Skin Sens. 1 |
|||
|
200-471-4
|
60-34-4
|
Carc. 1B |
|||
|
204-064-2
|
115-09-3
|
Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1 |
|||